home / stock / vtgn / vtgn news


VTGN News and Press, VistaGen Therapeutics Inc. From 08/31/20

Stock Information

Company Name: VistaGen Therapeutics Inc.
Stock Symbol: VTGN
Market: NASDAQ
Website: vistagen.com

Menu

VTGN VTGN Quote VTGN Short VTGN News VTGN Articles VTGN Message Board
Get VTGN Alerts

News, Short Squeeze, Breakout and More Instantly...

VTGN - (LD Micro) 360 Companies Set to Present - this Week

LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. Registration details and the company schedule can be seen here: https://ld500.ldmicro.co...

VTGN - VistaGen Therapeutics to Present at the LD Micro 500 Virtual Conference

SOUTH SAN FRANCISCO, Calif. , Aug. 27, 2020 /PRNewswire/ -- VistaGen Therapeutics, Inc. (Nasdaq: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (CNS) disorders, today announced that the Company will...

VTGN - Top Penny Stocks To Watch If You Like Biotech Right Now

Like Biotech Penny Stocks? Check Out Some Of These This year, penny stocks have been a topic of conversation among plenty of traders. This is due, in part, to the fact that many higher-priced stocks fell hard in March. I won’t go into how many of those “leading companies”...

VTGN - VistaGen Therapeutics reports FQ1 results

VistaGen Therapeutics (NASDAQ: VTGN ) : FQ1 GAAP EPS of -$0.07. More news on: VistaGen Therapeutics, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...

VTGN - VistaGen Therapeutics Reports Fiscal 2021 First Quarter Financial Results and Highlights CNS Pipeline and Business Progress

SOUTH SAN FRANCISCO, Calif. , Aug. 13, 2020 /PRNewswire/ -- VistaGen Therapeutics, Inc. (Nasdaq: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (CNS) disorders, today reported financial results for ...

VTGN - VistaGen Therapeutics Announces Exercise and Closing of Underwriters' Over-allotment Option in Underwritten Public Offering

SAN FRANCISCO , Aug. 10, 2020 /PRNewswire/ -- VistaGen Therapeutics, Inc. (Nasdaq: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (CNS) disorders, today announced the underwriters of its previously annou...

VTGN - Week In Review: BioKangtai Acquires China Rights To AstraZeneca's COVID-19 Vaccine

COVID-19 Pandemic BioKangtai (SHZ: 300601), a Guangdong vaccine company, in-licensed rights to develop, manufacture and market AstraZeneca's (AZN) COVID-19 vaccine in China. The candidate is an adenovirus vector-based COVID-19 vaccine that was created by Oxford University and partnered b...

VTGN - Does Your List Of Penny Stocks Have These 3 Names On It Right Now?

3 Penny Stocks To Watch In August 2020 When you talk about finding penny stocks to buy, where do you usually start looking? I’m sure you’ve got some type of basic scanning strategy. You may also have your “go-to” websites to get some info – hopefully PennyS...

VTGN - Looking For Cheap Penny Stocks To Buy? 4 Trading Under $2 Right Now

4 Cheap Stocks To Watch This Week Penny stocks are definitely considered “affordable” but let’s not get than confused with “cheap”. When it comes to these small- and micro-cap companies, the price tag of the stock itself shouldn’t be the only thing y...

VTGN - VistaGen Therapeutics Announces Closing of $12.5 Million Underwritten Public Offering

SOUTH SAN FRANCISCO, Calif. , Aug. 5, 2020 /PRNewswire/ -- VistaGen Therapeutics, Inc. (Nasdaq: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (CNS) disorders, today announced the closing of its pre...

Previous 10 Next 10